title: Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells.
abstract: Ex-vivo generation of human insulin-producing cells is considered a promising approach to providing an abundant source of cells for beta-cell replacement therapy in diabetes. Expansion of adult beta-cells from the limited number of islet donors is an attractive prospect. However, while evidence supports the replicative capacity of both rodent and human beta-cells in vivo, attempts at expanding these cells in tissue culture result in loss of beta-cell phenotype, making it difficult to track their fate during continuous propagation and raising doubts about their therapeutic potential. Recent lineage-tracing studies demonstrate the ability of human beta-cells to survive and replicate to a significant degree in vitro. Beta-cell delamination out of the normal epithelial structure, a process that results in dedifferentiation, seems to be required for significant in-vitro proliferation. Therefore, ways must be found of inducing redifferentiation of the expanded cells ex vivo, or of restoring their function upon transplantation. Elucidation of the signaling pathways altered during beta-cell adaptation to growth in culture may provide clues to cell redifferentiation. In a recent study, we found that human beta-cell dedifferentiation and entrance into the cell cycle in vitro correlated with activation of the Notch pathway and downregulation of the cell cycle inhibitor p57. Inhibition of the Notch downstream target HES1 using short hairpin RNA reduced beta-cell dedifferentiation and replication, suggesting a potential target for inducing cell redifferentiation following expansion in culture. This review critically discusses the potential for using ex-vivo beta-cell replication and redifferentiation in cell replacement therapy in diabetes.
authors.affiliation: Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, 69978 Israel.
authors.forename: Shimon
authors.initials: S
authors.lastname: Efrat
references.citation: PLoS Biol. 2007 Jul;5(7):e163
references.pmid: 17535113
references.citation: Biochem Biophys Res Commun. 2006 Mar 10;341(2):291-8
references.pmid: 16446152
references.citation: Diabetes. 2008 Jun;57(6):1575-83
references.pmid: 18316362
references.citation: Mol Cell Endocrinol. 2007 May 30;270(1-2):87-93
references.pmid: 17363142
references.citation: Cell. 2008 Jan 25;132(2):197-207
references.pmid: 18243096
references.citation: Biochem Biophys Res Commun. 2005 Feb 11;327(2):581-8
references.pmid: 15629153
references.citation: Diabetes. 2007 Mar;56(3):703-8
references.pmid: 17327439
references.citation: Nature. 2004 May 6;429(6987):41-6
references.pmid: 15129273
references.citation: J Clin Invest. 2004 Oct;114(7):963-8
references.pmid: 15467835
references.citation: Endocr Rev. 2006 Jun;27(4):356-70
references.pmid: 16638909
references.citation: Biochem Soc Trans. 2008 Jun;36(Pt 3):353-6
references.pmid: 18481956
references.citation: Diabetes. 2001 Feb;50 Suppl 1:S25-9
references.pmid: 11272193
references.citation: Diabetes. 2007 Jan;56(1):3-7
references.pmid: 17110468
references.citation: Cell Prolif. 2008 Jun;41(3):474-91
references.pmid: 18422699
references.citation: Diabetes. 2000 Aug;49(8):1325-33
references.pmid: 10923633
references.citation: Lab Invest. 2006 Feb;86(2):141-53
references.pmid: 16402034
references.citation: Diabetologia. 2008 Jan;51(1):91-100
references.pmid: 17994216
references.citation: Diabetologia. 1979 Feb;16(2):97-100
references.pmid: 365659
references.citation: Diabetes. 2002 Dec;51(12):3435-9
references.pmid: 12453897
references.citation: Diabetes. 2008 Sep;57(9):2413-20
references.pmid: 18599525
references.citation: Diabetes. 2007 Jul;56(7):1802-9
references.pmid: 17473224
references.citation: Diabetes. 2008 Jun;57(6):1584-94
references.pmid: 18334605
references.citation: Diabetes. 2008 Apr;57(4):958-66
references.pmid: 18083786
references.citation: Diabetes. 1995 Dec;44(12):1458-60
references.pmid: 7589854
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7999-8004
references.pmid: 10884429
references.citation: J Clin Invest. 2007 Sep;117(9):2553-61
references.pmid: 17786244
references.citation: Diabetologia. 2005 Nov;48(11):2296-304
references.pmid: 16193291
references.citation: J Clin Endocrinol Metab. 1997 Jun;82(6):1852-6
references.pmid: 9177395
references.citation: Stem Cells. 2007 Dec;25(12):3215-22
references.pmid: 17901402
references.citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3401-9
references.pmid: 15769977
references.citation: Cell Death Differ. 2007 Nov;14(11):1860-71
references.pmid: 17612586
references.citation: Diabetes. 2007 May;56(5):1299-304
references.pmid: 17303800
references.citation: Dev Cell. 2007 May;12(5):817-26
references.pmid: 17488631
references.citation: Diabetologia. 2005 Nov;48(11):2221-8
references.pmid: 16205882
references.citation: Stem Cells. 2007 Dec;25(12):3223-33
references.pmid: 17901401
references.citation: Annu Rev Cell Dev Biol. 2006;22:311-38
references.pmid: 16824015
references.citation: Diabetes. 2007 Mar;56(3):699-702
references.pmid: 17327438
references.citation: Science. 2004 Dec 24;306(5705):2261-4
references.pmid: 15564314
references.citation: Diabetes. 1999 May;48(5):1013-9
references.pmid: 10331405
references.citation: Diabetes. 2003 Jan;52(1):102-10
references.pmid: 12502499